ClassID:

242655

Y10S514/893 - CPC Classification

Classification description:

Sub-classes:
Recent Application in this class:
#1
20210205254
2021-07-08

OMEGA-3 PENTAENOIC ACID COMPOSITIONS AND METHODS OF USE

#2
20200085856
2020-03-19

ION BINDING POLYMERS AND USES THEREOF

#3
20190300564
2019-10-03

STEROIDS AS AGONISTS FOR FXR

#4
20180185330
2018-07-05

NOVEL COMPOSITION FOR NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)

#5
20170305961
2017-10-26

Steroids as agonists for FXR

#6
20170087127
2017-03-30

Composition for nonalcoholic fatty liver disease (NAFLD)

#7
20160317572
2016-11-03

Ion binding polymers and uses thereof

#8
20160152657
2016-06-02

Steroids as agonists for FXR

#9
20150320769
2015-11-12

Sulfated-oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation

#10
20140100273
2014-04-10

Methods of administering compositions comprising docosapentaenoic acid

#11
20140096548
2014-04-10

Humidity collector apparatus

#12
20140094520
2014-04-03

Omega-3 pentaenoic acid compositions and methods of use

#13
20140086984
2014-03-27

Pharmaceutical use of 2-(4-morpholinoaniline)-6-cyclohexyl aminopurine and/or salt thereof for improving liver functioning

#14
20140024631
2014-01-23

Steroids as agonists for FXR

#15
20130272992
2013-10-17

Ion binding polymers and uses thereof

#16
20130011464
2013-01-10

DRUG CARRIER AND DRUG CARRIER KIT FOR INHIBITING FIBROSIS

#17
20120264816
2012-10-18

Sulfated oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation

#18
20120189691
2012-07-26

Drug carrier and drug carrier kit for inhibiting fibrosis

#19
20120114599
2012-05-10

Opioid and opioid-like compounds and uses thereof

#20
20120076852
2012-03-29

Drug carrier and drug carrier kit for inhibiting fibrosis

#21
20120053163
2012-03-01

Steroids as agonists for FXR

#22
20110206631
2011-08-25

Ion binding polymers and uses thereof

#23
20110033505
2011-02-10

Methods and compositions for treatment of ion imbalances

#24
20100152422
2010-06-17

Composition for preventing and treating acetaminophen inducing liver injury comprising the protein extract from

#25
20100022498
2010-01-28

Steroids as agonists for FXR

#26
20090169508
2009-07-02

Opioid and opioid-like compounds and uses thereof

#27
20090148533
2009-06-11

Ion binding compositions

#28
20090011054
2009-01-08

Method of inducing liver phase II enzymes

#29
20080241093
2008-10-02

Ion binding polymers and uses thereof

#30
20080241092
2008-10-02

Ion binding polymers and uses thereof

#31
20080233073
2008-09-25

Ion binding polymers and uses thereof

#32
20080193512
2008-08-14

Drug carrier and drug carrier kit for inhibiting fibrosis

#33
20080160112
2008-07-03

Pharmaceutical use of water-soluble fraction of

#34
20070142340
2007-06-21

Steroids as agonists for FXR

#35
20070110831
2007-05-17

Plant-based formulations for improving liver health

#36
20060188477
2006-08-24

Method of treatment of viral hepatitis C with interferon alpha 5

#37
20060177419
2006-08-10

Stimulating neutrophil function to treat inflammatory bowel disease

#38
20060045925
2006-03-02

Pharmaceutical use of Graptopetalum and related plants

#39
20060024265
2006-02-02

Methods and compositions for treatment of ion imbalances

#40
20050170027
2005-08-04

Hepatic disorder suppressant

#41
20050169884
2005-08-04

Method of treating Crohn's Disease using sargramostim

#42
20050164942
2005-07-28

Method for treating a viral infection related or a chemical toxin related hepatic injury with deltorphin D

#43
20050163877
2005-07-28

Hepatic disorder suppressant

#44
20050163875
2005-07-28

Hepatic disorder suppressant

#45
20050123628
2005-06-09

Compositions and methods useful for treating and preventing chronic liver disease, chronic HCV infection and non-alcoholic steatohepatitis

#46
20050112114
2005-05-26

Adsorbent for oral administration, and agent for treating or preventing renal or liver disease

#47
20050080064
2005-04-14

Steroids as agonists for FXR

#48
20050032785
2005-02-10

Methods of inhibiting metastases